School of Materials and Chemistry & Institute of Bismuth and Rhenium Science, University of Shanghai for Science and Technology, Shanghai 200093, China.
Shanghai Collaborative Innovation Center of Energy Therapy for Tumors, University of Shanghai for Science and Technology, Shanghai 200093, China.
Dalton Trans. 2022 Mar 1;51(9):3666-3675. doi: 10.1039/d1dt04315c.
Photodynamic therapy (PDT) is an effective non-invasive treatment for tumors. The structure of a photosensitizer has an important influence on light utilization and efficiency of singlet-oxygen generation. In this study, we synthesized three π-type iridium(III) complexes and modified the C^N and N^N ligands with benzothiazole (BTZ) to regulate their light-absorption capacity and efficiency of singlet-oxygen generation. We assembled the nano-photosensitizers by wrapping them with an amphiphilic polyethylene glycol polymer with folic acid-targeting function to improve their targeting ability and biocompatibility. Modification of the BTZ group on the C^N ligand enhanced the ability of the photosensitizer to generate singlet oxygen and improved the cell uptake and PDT efficacy of the corresponding nanophotosensitizer. We believe that this type of photosensitizer provides the basis for the design of new photosensitizers based on the structure of iridium(III) complexes.
光动力疗法(PDT)是一种有效的肿瘤非侵入性治疗方法。光敏剂的结构对单线态氧的生成和利用有重要影响。本研究合成了三种π型铱(III)配合物,并对 C^N 和 N^N 配体进行了苯并噻唑(BTZ)修饰,以调节其光吸收能力和单线态氧生成效率。我们通过包裹具有叶酸靶向功能的两亲性聚乙二醇聚合物来组装纳米光敏剂,以提高其靶向能力和生物相容性。C^N 配体上 BTZ 基团的修饰增强了光敏剂生成单线态氧的能力,提高了相应纳米光敏剂的细胞摄取和 PDT 效果。我们相信,这种类型的光敏剂为基于铱(III)配合物结构的新型光敏剂设计提供了依据。